↓ Skip to main content

Unblinding at disease progression in double-blinded randomized controlled cancer drug clinical trials: A controversy requires more attention

Overview of attention for article published in Frontiers in Medicine, December 2022
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
10 Mendeley